INDO US BIO-TECH | SHEEL INTERN. | INDO US BIO-TECH/ SHEEL INTERN. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.6 | 39.2 | 108.5% | View Chart |
P/BV | x | 8.0 | 3.7 | 215.4% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH SHEEL INTERN. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-24 |
SHEEL INTERN. Mar-23 |
INDO US BIO-TECH/ SHEEL INTERN. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 304 | 19 | 1,603.1% | |
Low | Rs | 90 | 7 | 1,342.8% | |
Sales per share (Unadj.) | Rs | 36.3 | 0.1 | 24,490.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 3.3 | 124.3% | |
Cash flow per share (Unadj.) | Rs | 4.5 | 3.3 | 135.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 31.3 | 4.0 | 779.5% | |
Shares outstanding (eoy) | m | 20.05 | 6.00 | 334.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 86.7 | 6.3% | |
Avg P/E ratio | x | 47.9 | 3.9 | 1,235.6% | |
P/CF ratio (eoy) | x | 43.6 | 3.8 | 1,134.5% | |
Price / Book Value ratio | x | 6.3 | 3.2 | 197.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 3,951 | 77 | 5,134.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 9 | 3 | 281.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 728 | 1 | 81,838.2% | |
Other income | Rs m | 3 | 30 | 10.7% | |
Total revenues | Rs m | 732 | 31 | 2,379.1% | |
Gross profit | Rs m | 108 | -10 | -1,094.7% | |
Depreciation | Rs m | 8 | 0 | 5,714.3% | |
Interest | Rs m | 15 | 0 | 151,900.0% | |
Profit before tax | Rs m | 88 | 20 | 443.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 6 | 0 | -27,650.0% | |
Profit after tax | Rs m | 83 | 20 | 415.5% | |
Gross profit margin | % | 14.8 | -1,109.2 | -1.3% | |
Effective tax rate | % | 6.3 | -0.1 | -6,664.0% | |
Net profit margin | % | 11.3 | 2,231.2 | 0.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 731 | 8 | 8,660.1% | |
Current liabilities | Rs m | 175 | 1 | 17,640.4% | |
Net working cap to sales | % | 76.4 | 837.0 | 9.1% | |
Current ratio | x | 4.2 | 8.5 | 49.1% | |
Inventory Days | Days | 1 | 5,565 | 0.0% | |
Debtors Days | Days | 95,439,526 | 1,296,161,343 | 7.4% | |
Net fixed assets | Rs m | 107 | 18 | 581.5% | |
Share capital | Rs m | 201 | 60 | 334.5% | |
"Free" reserves | Rs m | 427 | -36 | -1,190.6% | |
Net worth | Rs m | 627 | 24 | 2,604.7% | |
Long term debt | Rs m | 28 | 0 | - | |
Total assets | Rs m | 838 | 27 | 3,120.9% | |
Interest coverage | x | 6.8 | 1,985.0 | 0.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0 | 2,622.2% | |
Return on assets | % | 11.7 | 74.0 | 15.8% | |
Return on equity | % | 13.2 | 82.4 | 16.0% | |
Return on capital | % | 15.7 | 82.4 | 19.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -46 | 8 | -562.2% | |
From Investments | Rs m | 43 | -13 | -341.0% | |
From Financial Activity | Rs m | 12 | 4 | 303.0% | |
Net Cashflow | Rs m | 9 | 0 | -2,456.8% |
Indian Promoters | % | 70.2 | 15.5 | 451.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 84.5 | 35.3% | |
Shareholders | 973 | 19,610 | 5.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | SHEEL INT. |
---|---|---|
1-Day | -1.42% | -4.74% |
1-Month | -0.82% | -16.05% |
1-Year | 34.47% | 0.34% |
3-Year CAGR | 79.07% | 5.77% |
5-Year CAGR | 54.26% | 43.76% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the SHEEL INT. share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of SHEEL INT. the stake stands at 15.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of SHEEL INT..
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
SHEEL INT. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of SHEEL INT..
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.